Prospective Clinical Assessment Study in Children With Hypochondroplasia

NCT06410976 · clinicaltrials.gov ↗
RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Sponsor

QED Therapeutics, a BridgeBio company